Search research articles
Contact Us
Filters
Showing results (81-90 of 84) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 84 results.
The Journal of Experimental Medicine
|
November 25, 2018
Bone marrow-derived fibroblasts are a functionally distinct stromal cell population in breast cancer
Yael Raz, Noam Cohen, Ophir Shani, et al.
International Journal of Cancer
|
November 5, 2016
Quercetin alters the DNA damage response in human hematopoietic stem and progenitor cells via TopoII- and PI3K-dependent mechanisms synergizing in leukemogenic rearrangements
Shahar Biechonski, Dana Gourevich, Melanie Rall, et al.
Scientific Reports
|
April 19, 2018
Attenuated DNA damage responses and increased apoptosis characterize human hematopoietic stem cells exposed to irradiation
Shahar Biechonski, Leonid Olender, Adi Zipin-Roitman, et al.
Biomedicines
|
September 23, 2022
Comparing Intraperitoneal and Intravenous Personalized ErbB2CAR-T for the Treatment of Epithelial Ovarian Cancer
Naamit Deshet-Unger, Galit Horn, Moran Rawet-Slobodkin, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 84) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 84 results.
The Journal of Experimental Medicine
|
November 25, 2018
Bone marrow-derived fibroblasts are a functionally distinct stromal cell population in breast cancer
Yael Raz, Noam Cohen, Ophir Shani, et al.
International Journal of Cancer
|
November 5, 2016
Quercetin alters the DNA damage response in human hematopoietic stem and progenitor cells via TopoII- and PI3K-dependent mechanisms synergizing in leukemogenic rearrangements
Shahar Biechonski, Dana Gourevich, Melanie Rall, et al.
Scientific Reports
|
April 19, 2018
Attenuated DNA damage responses and increased apoptosis characterize human hematopoietic stem cells exposed to irradiation
Shahar Biechonski, Leonid Olender, Adi Zipin-Roitman, et al.
Biomedicines
|
September 23, 2022
Comparing Intraperitoneal and Intravenous Personalized ErbB2CAR-T for the Treatment of Epithelial Ovarian Cancer
Naamit Deshet-Unger, Galit Horn, Moran Rawet-Slobodkin, et al.
Page
of 9